Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2013
11/20/2013CN103394348A Method for preparing catalyst for hydrogenating pyridine compound and application thereof
11/20/2013CN101611021B Organic molybdenum compounds and oil compositions containing the same
11/19/2013US8586750 Method for the production of halogen-substituted 2-(aminomethylidene)-3-oxobutyric acid esters
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013US8586576 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/19/2013CA2759341C Low-voc polyamines
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/19/2013CA2552356C Catalytic radiofluorination
11/14/2013WO2013167633A1 Acrylamide compounds for combating invertebrate pests
11/14/2013WO2013167583A1 Pharmaceutical composition of a papillomavirus inhibitor
11/14/2013US20130303757 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/14/2013US20130303572 Novel inhibitors of matrix metalloproteinases
11/14/2013US20130303545 Cyclopropylamine derivatives useful as lsd1 inhibitors
11/14/2013US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303505 Tgr5 agonists
11/13/2013EP2662353A2 Antibacterial agents
11/13/2013CN103387554A Novel method for preparing ima acid
11/13/2013CN103387553A Synthetic method of fluorine-containing benzophenone photoinitiator
11/13/2013CN102617512B Method for preparation of tetrahydropyrrole
11/13/2013CN102604088B Macromolecule mercaptan and synthetic method thereof
11/13/2013CN102408286B Preparation method of N,N-disubstituted sulfonamide compound
11/12/2013US8580802 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
11/12/2013US8580782 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/12/2013US8580297 Components for producing amphoteric liposomes
11/12/2013CA2597622C Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013US20130296556 Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms
11/07/2013US20130296335 Certain chemical entities, compositions, and methods
11/07/2013US20130296334 Organic amine salts of azilsartan, preparation method and use thereof
11/07/2013US20130296323 Gga and gga derivatives compositions thereof and methods for treating neurodegenerative diseases including paralysis including them
11/07/2013US20130296295 Bcl-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/06/2013EP2659884A2 Selective apoptotic induction in cancer cells including activation of procaspase-3
11/06/2013CN103382192A Preparation of N-monosubstituted piperazine derivatives
11/06/2013CN103382191A Preparation method of 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
11/06/2013CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments
11/06/2013CN102225919B Curcumin analogue and preparation method thereof as well as application thereof in preparation of Alzheimer disease resisting medicament
11/05/2013US8575170 Flurbiprofen analogs and methods of use in treating cancer
11/05/2013US8575135 Antiviral compounds
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013US20130289270 Amination of Aryl Alcohol Derivatives
10/31/2013US20130289049 Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof as bradykinin b1 receptorantagonists
10/31/2013US20130289043 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
10/31/2013US20130289034 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
10/30/2013EP2657225A2 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates
10/30/2013CN1989099B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
10/30/2013CN103373973A Novel synthetic process for levocetirizine and key intermediates
10/30/2013CN102079707B Mesitylene group aromatic ketone compound, preparation method thereof and photoinitiator
10/30/2013CN101591230B 2,4-dyhydroxyl chalcone derivative, preparation method and application thereof
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/29/2013US8569499 Process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
10/29/2013US8569498 Process for the preparation of piperazine compounds and hydrochloride salts thereof
10/29/2013US8569497 Process for the preparation of piperazine derivatives
10/29/2013US8569496 Piperazine salt and a process for the preparation thereof
10/29/2013US8569495 Anthelmintic agents and their use
10/29/2013US8569304 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof
10/29/2013US8569267 Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain
10/24/2013WO2013156155A1 Substituted 4-aminobenzamides as kcnq2/3 modulators
10/24/2013US20130281700 Palladium catalyst, method for its preparation and its use
10/24/2013US20130281452 Substituted 4-aminobenzamides as kcnq2/3 modulators
10/24/2013US20130281448 Small molecule compounds for targeting inflammatory conditions
10/24/2013US20130281436 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
10/24/2013US20130281426 Pyridazinones, the preparation method and the use thereof
10/23/2013EP2651907A1 Bleach catalysts
10/23/2013CN103360358A 15-oxospiramilactone derivatives, and preparation method and applications thereof
10/23/2013CN103360343A Preparation method of piperazine amide compound
10/23/2013CN103360342A 3-Cyanoaniline alkyl aryl piperazine derivative and application in preparing medicaments
10/23/2013CN103360341A Tertiary leucine derived chiral amine compound as well as preparation method and application thereof
10/23/2013CN103360340A Synthetic method for N-(2-chloroethyl) hexamethyleneimine hydrochloride
10/23/2013CN103360294A Compound with antituberculous activity, as well as preparation method and application thereof
10/23/2013CN103360272A Quaternary ammonium salt preparation method and application thereof
10/23/2013CN103360270A Serine derived chiral amine compound as well as preparation method and application thereof
10/23/2013CN102146007B Method for preparing secondary amine and tertiary amine
10/23/2013CN101796026B Guanidine-containing compounds useful as muscarinic receptor antagonists
10/22/2013US8563544 2,5-disubstituted arylsulfonamide CCR3 antagonists
10/22/2013US8563533 Soft protease inhibitors and pro-soft forms thereof
10/17/2013WO2013153873A1 Photosensitive compound, photosensitive resin, and photosensitive composition
10/17/2013WO2013152548A1 Catalyst for synthesizing ethylene amine and method for preparing ethylene amine
10/17/2013US20130274270 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/16/2013EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/16/2013EP2650011A1 Method of treatment or prophylaxis
10/16/2013CN103351362A Preparation method of manidipine intermediate 2-(4-diphenylmethyl piperazinyl)ethyl acetoacetate
10/16/2013CN103351361A Levocetirizine preparation method and levocetirizine dihydrochloride preparation method
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557820 Crystal modifications of transmission dyes
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2697256C Cyclopropyl amide derivatives
10/10/2013WO2013102097A3 Cyclic amine compounds, compositions, and polyurethane foams made therefrom
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267712 Aromatic ketone synthesis with amide reagents and related reactions
10/10/2013US20130267707 N,N+hu 1 +l SUBSTITUTED PIPERAZINES HAVING COMBINED ANTIAGGREGANT, ANTICOAGULANT AND VASODILATORY ACTIVITY, AND METHOD FOR PRODUCING SAME
10/10/2013US20130267704 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
10/10/2013US20130267703 Compounds useful for treating aids
10/10/2013US20130267538 Treatment of mitochondrial diseases
10/10/2013US20130267537 Heterocyclic sulfonamides
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 341